Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment.
Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing.
Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir.
Galectin-8 elicits pro-inflammatory activities in the endothelium.
Cell cycle control and HIV-1 susceptibility are linked by CDK6-dependent CDK2 phosphorylation of SAMHD1 in myeloid and lymphoid cells.
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure.
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control.
HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein.